Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Multinational Study Of Efficacy And Safety Of Varenicline Tartrate For Smoking Cessation

NCT00371813 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00371813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00371813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Multinational Study Of Efficacy And Safety Of Varenicline Tartrate For Smoking Cessation
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2006
Completion date
June 30, 2007
Enrollment
334 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation